Tazarotene
- Product NDC
- 0713-0764
- 11-digit product format
- 007130764
- Labeler code
- 0713
- Product ID
- 0713-0764_dde31e80-c02a-1552-e053-2a95a90a9f0e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tazarotene
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Cosette Pharmaceuticals, Inc.
- Application
- ANDA208662
- Marketing category
- ANDA
- Marketing start
- 2020-08-24
- Marketing end
- 2022-09-30
- Substance
- TAZAROTENE
- Active strength
- 1 mg/g
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0713-0764-31 | 00713076431 | 1 TUBE in 1 CARTON (0713-0764-31) > 30 g in 1 TUBE | 1 tube | 2020-08-24 | 0000-00-00 | No | No | Current |
| 0713-0764-60 | 00713076460 | 1 TUBE in 1 CARTON (0713-0764-60) > 60 g in 1 TUBE | 1 tube | 2020-08-24 | 0000-00-00 | No | No | Current |